Literature DB >> 12042117

Influence of phytostanol phosphoryl ascorbate, FM-VP4, on pancreatic lipase activity and cholesterol accumulation within Caco-2 cells.

Manisha Ramaswamy1, Edwin Yau, Kishor M Wasan, Kathy D Boulanger, Ming Li, P Haydn Pritchard.   

Abstract

PURPOSE: The objective of this study was to determine how a novel hydrophilic phytostanol (FM-VP4) affects the cellular accumulation of [3H]cholesterol in human colon carcinoma (Caco-2) cell monolayers grown in Transwell chambers.
METHODS: To determine cellular accumulation of cholesterol and FM-VP4, [3H]cholesterol- containing micelles (50 microM cholesterol containing 1.27x10 (-4)% [3H]cholesterol) or [3H]FM-VP4 (50 microM) was incubated on the apical side of differentiated Caco-2 cell monolayers for 1 to 4 h at 37 degrees C in the absence or presence of increasing concentrations (10-200 microM) of unlabeled FM-VP4 or cholesterol, respectively.
RESULTS: The accumulation of [3H]cholesterol (presented in micelles) into Caco-2 cell monolayers in the presence of 50 microM FM-VP4 was significantly lower (33.7 +/- 7.0%) compared to control (59.8 +/- 5.2%, p<0.05) following 4 h of incubation. Conversely, cholesterol inhibited the accumulation of [3H]FM-VP4, although to a lesser extent, suggesting competition for binding sites. The inhibitory effects of FM-VP4 and cholesterol on each other were detectable after 1 h of incubation and increased with time. The extent of FM-VP4 inhibition of [3H]cholesterol accumulation was consistent whether FM-VP4 was co-incorporated into micelles or added separately in solution, suggesting that FM-VP4 does not elicit its effects through inhibition of cholesterol incorporation into micelles. In addition, pancreatic lipase activity ([3H]triolein hydrolysis) and p-glycoprotein (rhodamine 123 fluorescence) activity, were not affected by FM-VP4.
CONCLUSIONS: In conclusion, FM-VP4 rapidly inhibits cholesterol accumulation within Caco-2 cell monolayers in a mode independent of pancreatic lipase activity, p-glycoprotein activity or cholesterol incorporation in micelles.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12042117

Source DB:  PubMed          Journal:  J Pharm Pharm Sci        ISSN: 1482-1826            Impact factor:   2.327


  5 in total

1.  Effects of a water-soluble phytostanol ester on plasma cholesterol levels and red blood cell fragility in hamsters.

Authors:  Naoyuki Ebine; Xiaoming Jia; Isabelle Demonty; Yanwen Wang; Peter J H Jones
Journal:  Lipids       Date:  2005-02       Impact factor: 1.880

2.  Phospholipase D-catalyzed synthesis of novel phospholipid-phytosterol conjugates.

Authors:  Monjur Hossen; Ernesto Hernandez
Journal:  Lipids       Date:  2004-08       Impact factor: 1.880

3.  Effects of disodium ascorbyl phytostanol phosphates (FM-VP4) on cholesterol accumulation within rat intestinal cells.

Authors:  Kishor M Wasan; Edwin Yau; Kathy D Boulanger; Manisha Ramswamy; P Haydn Pritchard
Journal:  AAPS PharmSci       Date:  2003

Review 4.  Inhibition of cholesterol absorption: targeting the intestine.

Authors:  Stephen D Lee; Pavel Gershkovich; Jerald W Darlington; Kishor M Wasan
Journal:  Pharm Res       Date:  2012-08-25       Impact factor: 4.200

5.  Efficacy and safety of disodium ascorbyl phytostanol phosphates in men with moderate dyslipidemia.

Authors:  Maud N Vissers; Mieke D Trip; P Haydn Pritchard; Patrick Tam; Tatjana Lukic; Monique G de Sain-van der Velden; Martina de Barse; John J P Kastelein
Journal:  Eur J Clin Pharmacol       Date:  2008-03-05       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.